Patient-specific driver gene prediction and risk assessment through integrated network analysis of cancer omics profiles
暂无分享,去创建一个
Kern Rei Chng | N. Nagarajan | E. Liu | Y. Sia | A. Hillmer | D. Bertrand | D. Hoon | S. Huang | F. G. Sherbaf | Anja Kiesel | B. Chia
[1] W. Huber,et al. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2 , 2014, Genome Biology.
[2] Frank McCormick,et al. Targeting RAF kinases for cancer therapy: BRAF-mutated melanoma and beyond , 2014, Nature Reviews Cancer.
[3] Xiaoning Peng,et al. An Integrated mRNA and microRNA Expression Signature for Glioblastoma Multiforme Prognosis , 2014, PloS one.
[4] Benjamin Frederick Ganzfried,et al. Comparative meta-analysis of prognostic gene signatures for late-stage ovarian cancer. , 2014, Journal of the National Cancer Institute.
[5] Neal P. Kawas,et al. Epigenome-wide DNA methylation landscape of melanoma progression to brain metastasis reveals aberrations on homeobox D cluster associated with prognosis. , 2014, Human molecular genetics.
[6] P. Stephens,et al. BRAF Fusions Define a Distinct Molecular Subset of Melanomas with Potential Sensitivity to MEK Inhibition , 2013, Clinical Cancer Research.
[7] Gary D Bader,et al. Comprehensive identification of mutational cancer driver genes across 12 tumor types , 2013, Scientific Reports.
[8] Andrew M. Gross,et al. Network-based stratification of tumor mutations , 2013, Nature Methods.
[9] David Tamborero,et al. OncodriveCLUST: exploiting the positional clustering of somatic mutations to identify cancer genes , 2013, Bioinform..
[10] F. Gnad,et al. Assessment of computational methods for predicting the effects of missense mutations in human cancers , 2013, BMC Genomics.
[11] Steven J. M. Jones,et al. Integrated genomic characterization of endometrial carcinoma , 2013, Nature.
[12] K. Kinzler,et al. Cancer Genome Landscapes , 2013, Science.
[13] Lei Wang,et al. Over-expression of BCAT1, a c-Myc target gene, induces cell proliferation, migration and invasion in nasopharyngeal carcinoma , 2013, Molecular Cancer.
[14] A. Bashashati,et al. DriverNet: uncovering the impact of somatic driver mutations on transcriptional networks in cancer , 2012, Genome Biology.
[15] Niranjan Nagarajan,et al. Long Span DNA Paired-End-Tag (DNA-PET) Sequencing Strategy for the Interrogation of Genomic Structural Mutations and Fusion-Point-Guided Reconstruction of Amplicons , 2012, PloS one.
[16] David Haussler,et al. PARADIGM-SHIFT predicts the function of mutations in multiple cancers using pathway impact analysis , 2012, Bioinform..
[17] A. Gonzalez-Perez,et al. Functional impact bias reveals cancer drivers , 2012, Nucleic acids research.
[18] Michael R. Hayden,et al. Whole-Genome Sequencing: The New Standard of Care? , 2012, Science.
[19] T. Fennell,et al. Melanoma genome sequencing reveals frequent PREX2 mutations , 2012, Nature.
[20] Adam A. Margolin,et al. The Cancer Cell Line Encyclopedia enables predictive modeling of anticancer drug sensitivity , 2012, Nature.
[21] David R. Kelley,et al. Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and Cufflinks , 2012, Nature Protocols.
[22] Zhengyan Kan,et al. Exome sequencing identifies frequent mutation of ARID1A in molecular subtypes of gastric cancer , 2011, Nature Genetics.
[23] L. Pusztai,et al. Gene expression profiling in breast cancer: classification, prognostication, and prediction , 2011, The Lancet.
[24] Stephen J. Salipante,et al. Exome sequencing identifies a spectrum of mutation frequencies in advanced and lethal prostate cancers , 2011, Proceedings of the National Academy of Sciences.
[25] Huanming Yang,et al. Frequent mutations of chromatin remodeling genes in transitional cell carcinoma of the bladder , 2011, Nature Genetics.
[26] J. Mesirov,et al. Systematic investigation of genetic vulnerabilities across cancer cell lines reveals lineage-specific dependencies in ovarian cancer , 2011, Proceedings of the National Academy of Sciences.
[27] Juliane C. Dohm,et al. Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia , 2011, Nature.
[28] C. Sander,et al. Predicting the functional impact of protein mutations: application to cancer genomics , 2011, Nucleic acids research.
[29] R. Karchin,et al. Correlation of somatic mutation and expression identifies genes important in human glioblastoma progression and survival. , 2011, Cancer research.
[30] Benjamin J. Raphael,et al. Integrated Genomic Analyses of Ovarian Carcinoma , 2011, Nature.
[31] S. Davis,et al. Exome sequencing identifies GRIN2A as frequently mutated in melanoma , 2011, Nature Genetics.
[32] Kamil Erguler,et al. Practical limits for reverse engineering of dynamical systems: a statistical analysis of sensitivity and parameter inferability in systems biology models. , 2011, Molecular bioSystems.
[33] Eli Upfal,et al. De Novo Discovery of Mutated Driver Pathways in Cancer , 2011, RECOMB.
[34] D. Hanahan,et al. Hallmarks of Cancer: The Next Generation , 2011, Cell.
[35] Jannik N. Andersen,et al. Cancer genomics: from discovery science to personalized medicine , 2011, Nature Medicine.
[36] Trevor J Pugh,et al. Initial genome sequencing and analysis of multiple myeloma , 2011, Nature.
[37] Teresa M. Przytycka,et al. Identifying Causal Genes and Dysregulated Pathways in Complex Diseases , 2011, PLoS Comput. Biol..
[38] Richard Simon,et al. Identifying cancer driver genes in tumor genome sequencing studies , 2011, Bioinform..
[39] D. Pe’er,et al. An Integrated Approach to Uncover Drivers of Cancer , 2010, Cell.
[40] M. DePristo,et al. The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. , 2010, Genome research.
[41] C. Sander,et al. Integrative genomic profiling of human prostate cancer. , 2010, Cancer cell.
[42] L. Stein,et al. A human functional protein interaction network and its application to cancer data analysis , 2010, Genome Biology.
[43] R. Schilsky. Personalized medicine in oncology: the future is now , 2010, Nature Reviews Drug Discovery.
[44] Eli Upfal,et al. Algorithms for Detecting Significantly Mutated Pathways in Cancer , 2010, RECOMB.
[45] Gary D Bader,et al. International network of cancer genome projects , 2010, Nature.
[46] Brendan Borrell,et al. How accurate are cancer cell lines? , 2010, Nature.
[47] C. Sander,et al. Automated Network Analysis Identifies Core Pathways in Glioblastoma , 2010, PloS one.
[48] Renaud Gaujoux,et al. A flexible R package for nonnegative matrix factorization , 2010, BMC Bioinformatics.
[49] Leyla Isik,et al. Cancer-specific high-throughput annotation of somatic mutations: computational prediction of driver missense mutations. , 2009, Cancer research.
[50] J. Qin,et al. Trim24 targets endogenous p53 for degradation , 2009, Proceedings of the National Academy of Sciences.
[51] N. Schork,et al. Identification of rare cancer driver mutations by network reconstruction. , 2009, Genome research.
[52] Gonçalo R. Abecasis,et al. The Sequence Alignment/Map format and SAMtools , 2009, Bioinform..
[53] M. Somerfield,et al. American Society of Clinical Oncology provisional clinical opinion: testing for KRAS gene mutations in patients with metastatic colorectal carcinoma to predict response to anti-epidermal growth factor receptor monoclonal antibody therapy. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[54] M. Stratton,et al. The cancer genome , 2009, Nature.
[55] Antoine M. van Oijen,et al. Real-time single-molecule observation of rolling-circle DNA replication , 2009, Nucleic acids research.
[56] Brad T. Sherman,et al. Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists , 2008, Nucleic acids research.
[57] Joshua M. Korn,et al. Comprehensive genomic characterization defines human glioblastoma genes and core pathways , 2008, Nature.
[58] R. Bernards,et al. Enabling personalized cancer medicine through analysis of gene-expression patterns , 2008, Nature.
[59] R. Sharan,et al. Protein networks in disease. , 2008, Genome research.
[60] D. Haber,et al. Cancer: Drivers and passengers , 2007, Nature.
[61] E. Birney,et al. Patterns of somatic mutation in human cancer genomes , 2007, Nature.
[62] T. Hubbard,et al. A census of human cancer genes , 2004, Nature Reviews Cancer.
[63] L. Bullinger,et al. Genetics of chronic lymphocytic leukemia: genomic aberrations and VH gene mutation status in pathogenesis and clinical course , 2002, Leukemia.
[64] A. Fukui,et al. Inhibition of the Wnt Signaling Pathway by Idax, a Novel Dvl-Binding Protein , 2001, Molecular and Cellular Biology.
[65] M. Wolter,et al. Amplification and overexpression of the MDM4 (MDMX) gene from 1q32 in a subset of malignant gliomas without TP53 mutation or MDM2 amplification. , 1999, Cancer research.
[66] S. Lichtenstein,et al. Primary cardiac tumors , 1997, Cancer.
[67] J. C. FISHER,et al. Multiple-Mutation Theory of Carcinogenesis , 1958, Nature.